Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- ALSPW.PA
- Price
- 0.16
- Stock movement up
- +0.00 (2.55%)
- Company name
- Spineway
- Exchange
- (PA ,
- Currency
- EUR )
- Sector
- Healthcare >Medical Instruments & Supplies
- Market cap
- 5.72M
- Ent value
- 8.04M
- Price/Sales
- 0.25
- Price/Book
- 0.24
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -96.36%
- 1 year return
- 35.18%
- 3 year return
- -
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-11-25
DIVIDENDS
ALSPW.PA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | 150.60 |
| EV to EBITDA | 211.49 |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.25 |
| Price to Book | 0.24 |
| EV to Sales | 0.35 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 35.54M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 4.03M |
| Net receivables | 3.04M |
| Total current assets | 13.40M |
| Goodwill | 5.90M |
| Intangible assets | 3.47M |
| Property, plant and equipment | 7.66M |
| Total assets | 30.20M |
| Accounts payable | 2.01M |
| Short/Current long term debt | 1.55M |
| Total current liabilities | 5.72M |
| Total liabilities | 6.34M |
| Shareholder's equity | 23.86M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.15 |
| Daily high | 0.16 |
| Daily low | 0.15 |
| Daily Volume | 261K |
| All-time high | 844800000.00 |
| 1y analyst estimate | 0.27 |
| Beta | 0.41 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ALSPW.PA | S&P500 | |
| Current price drop from All-time high | -100.00% | -1.80% |
| Highest price drop | -100.00% | -19.00% |
| Date of highest drop | 25 Nov 2025 | 8 Apr 2025 |
| Avg drop from high | -100.00% | -2.73% |
| Avg time to new high | - | 6 days |
| Max time to new high | 289 days | 89 days |
COMPANY DETAILS
Marketcap
5.72M
Marketcap category
Small-cap
Description
Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.
Employees
43
Website
Investor relations
-
SEC filings
CEO
Country
France
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Ecully, October 14, 2025 – 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M r...
October 14, 2025
Press release Ecully, July 30, 2025 – 7 p.m. SPINEWAY H1 2025 results Continued improvement in results and financial positionFull-year 2025 growth target confirmed In thousands of eurosConsolidated fi...
July 30, 2025
Press release Ecully, July 3, 2025 – 6:30 p.m. SPINEWAY GMED approval for new production line dedicated to ESP prostheses First production of LP-ESP intervertebral disc prostheses Spineway, a speciali...
July 3, 2025
Press release Ecully, June 6, 2025 – 6.00 p.m. SPINEWAY Minutes of the General Meeting of June 4, 2025 The Combined General Meeting (Ordinary and Extraordinary) of Spineway shareholders was held on fi...
June 6, 2025
Press release Ecully, May 19, 2025 – 6.30 p.m. SPINEWAY Combined General Meeting of June 4, 2025Availability of preparatory documents Spineway informs its shareholders that they are invited to attend ...
May 19, 2025
Press release Ecully, April 16, 2025 – 7.00 p.m. SPINEWAY First-quarter 2025 revenue of €2.8 million In thousands of euros20252024Change as a %Q1 revenue2,8283,070-8% Unaudited consolidated data Spine...
April 16, 2025
Press release Ecully, March 24, 2025 – 6 p.m. SPINEWAY Consolidated 2024 annual results Annual revenue of €12 million (+14%)Operating income close to breakevenReduction in net loss In thousands of eur...
March 24, 2025
Press release Ecully, February 27, 2025 – 6.30 p.m. Spineway marks its return to Arab Health 2025 with new distribution agreements Spineway, a specialist in innovative implants for the treatment of se...
February 27, 2025
Press release Ecully, January 22, 2025 – 6.30 p.m. SPINEWAY 2024 revenue of €12 million 14% growth compared with 2023 In thousands of euros20242023Change as a %H1 revenue6,5355,431+20%H2 revenue5,4155...
January 22, 2025
Press release Ecully, December 18, 2024 – 6 p.m. Spineway wins new approvals in Vietnam and registers initial orders The Spineway Group, a specialist in innovative implants for the treatment of severe...
December 18, 2024
Next page